Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)
| 0.64 Delayed Data As of May 30 |  0.00 / 0.00%Today’s Change | 0.50 Today|||52-Week Range 2.41 | -4.05% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Barker Samuel L Director |  Gift | 6/14/2022 | 15,822 | $0.00 | $0.00 | -42.34% |
Henney Christopher S Director | Gift | 6/14/2022 | 15,822 | $0.00 | $0.00 | -42.34% |
Schwartz Brian D Director | Gift | 6/14/2022 | 15,822 | $0.00 | $0.00 | -42.34% |
Sems Lloyd M Director | Gift | 6/14/2022 | 15,822 | $0.00 | $0.00 | -42.34% |
Spiegel Robert Jay Director | Gift | 6/14/2022 | 15,822 | $0.00 | $0.00 | -42.34% |
Walker Karin L Director | Gift | 6/14/2022 | 15,822 | $0.00 | $0.00 | -42.34% |
Ferguson Kenneth M Director | Gift | 6/14/2022 | 27,733 | $0.00 | $0.00 | -42.34% |
Ferguson Kenneth M Director | Gift | 6/14/2022 | 23,733 | $0.00 | $0.00 | -42.34% |
Kirschbaum Mark Chief Medical Officer | Gift | 1/31/2023 | 31,200 | $0.00 | $0.00 | -29.19% |
Rombotis Spiro President & Chief Executive Officer | Gift | 1/31/2023 | 57,600 | $0.00 | $0.00 | -29.19% |
Page of 2